Literature DB >> 9215749

Hematologically important mutations: Glanzmann thrombasthenia.

D L French1, B S Coller.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9215749     DOI： 10.1006/bcmd.1997.0117

Source DB:  PubMed          Journal:  Blood Cells Mol Dis        ISSN： 1079-9796            Impact factor:   3.039


× No keyword cloud information.
  13 in total

1.  TC21/RRas2 regulates glycoprotein VI-FcRγ-mediated platelet activation and thrombus stability.

Authors:  S Janapati; J Wurtzel; C Dangelmaier; B K Manne; D Bhavanasi; J C Kostyak; S Kim; M Holinstat; S P Kunapuli; L E Goldfinger
Journal:  J Thromb Haemost       Date:  2018-06-08       Impact factor: 5.824

2.  Novel Mutations in the GPIIb and GPIIIa Genes in Glanzmann Thrombasthenia.

Authors:  Daniele Pillitteri; Ann-Kathrin Pilgrimm; Carl Maximilian Kirchmaier
Journal:  Transfus Med Hemother       Date:  2010-09-15       Impact factor: 3.747

3.  Therapeutic expression of the platelet-specific integrin, alphaIIbbeta3, in a murine model for Glanzmann thrombasthenia.

Authors:  Juan Fang; Kairbaan Hodivala-Dilke; Bryon D Johnson; Lily M Du; Richard O Hynes; Gilbert C White; David A Wilcox
Journal:  Blood       Date:  2005-06-21       Impact factor: 22.113

4.  Three novel beta-propeller mutations causing Glanzmann thrombasthenia result in production of normally stable pro-alphaIIb, but variably impaired progression of pro-alphaIIbbeta3 from endoplasmic reticulum to Golgi.

Authors:  E J R Nelson; J Li; W B Mitchell; M Chandy; A Srivastava; B S Coller
Journal:  J Thromb Haemost       Date:  2005-12       Impact factor: 5.824

5.  Potential large animal models for gene therapy of human genetic diseases of immune and blood cell systems.

Authors:  Thomas R Bauer; Rima L Adler; Dennis D Hickstein
Journal:  ILAR J       Date:  2009

6.  Role of the beta-subunit arginine/lysine finger in integrin heterodimer formation and function.

Authors:  Vineet Gupta; José Luis Alonso; Takashi Sugimori; Makram Essafi; Makram Issafi; Jiang-Ping Xiong; M Amin Arnaout
Journal:  J Immunol       Date:  2008-02-01       Impact factor: 5.422

7.  Anaesthetic Management with Thromboelastography in a Patient with Glanzmann Thrombasthenia.

Authors:  Ahmet Topal; Alper Kılıçaslan; Atilla Erol; Barış Çankaya; Şeref Otelcioğlu
Journal:  Turk J Anaesthesiol Reanim       Date:  2014-05-29

8.  Hantaviruses direct endothelial cell permeability by sensitizing cells to the vascular permeability factor VEGF, while angiopoietin 1 and sphingosine 1-phosphate inhibit hantavirus-directed permeability.

Authors:  Irina N Gavrilovskaya; Elena E Gorbunova; Natalie A Mackow; Erich R Mackow
Journal:  J Virol       Date:  2008-03-26       Impact factor: 5.103

9.  Beta3-integrin-deficient mice are a model for Glanzmann thrombasthenia showing placental defects and reduced survival.

Authors:  K M Hodivala-Dilke; K P McHugh; D A Tsakiris; H Rayburn; D Crowley; M Ullman-Culleré; F P Ross; B S Coller; S Teitelbaum; R O Hynes
Journal:  J Clin Invest       Date:  1999-01       Impact factor: 14.808

10.  αIIbβ3 variants defined by next-generation sequencing: predicting variants likely to cause Glanzmann thrombasthenia.

Authors:  Lorena Buitrago; Augusto Rendon; Yupu Liang; Ilenia Simeoni; Ana Negri; Marta Filizola; Willem H Ouwehand; Barry S Coller
Journal:  Proc Natl Acad Sci U S A       Date:  2015-03-31       Impact factor: 11.205
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.